Wanbangde Pharmaceutical Hits Day Low of CNY 10.08 Amid Price Pressure

Wanbangde Pharmaceutical Holding Group Co., Ltd. experienced a significant decline today, with the stock dropping by 7.77% and reaching an intraday low of CNY 10.08. This performance contrasts sharply with the China Shanghai Composite, which gained 1.79% on the same day. Over the past week, Wanbangde's stock has decreased by 10.79%, and its monthly performance shows a decline of 24.32%. Despite a positive annual performance of 30.1%, the year-to-date results reveal a substantial drop of 25.84%. The company has faced challenges in long-term growth, with net sales declining at an annual rate of 36.85% and operating profit decreasing by 150.12% over the last five years. Additionally, the latest half-year results indicate a net profit of CNY -76.34 million, reflecting a staggering growth rate of -411.07%. With a market capitalization of CNY 8,117 million, Wanbangde remains net-debt free, but its return on equity stands at a low -3.56%, highlighting ongoing profitability concerns.